… antiphospholipid syndrome (… antiphospholipid antibodies such as lupus anticoagulant,
anti-β-2-glycoprotein 1, and/or anticardiolipin antibodies. In the obstetrical APS, antiphospholipid …

… also key drivers of APS pathophysiology. Thrombotic events in … This review will highlight
known pathogenic factors in APS … a barrier that selectively permits molecular and cellular transit …

… disorder, characterized by pregnancy morbidity and/or a hyper coagulable state involving
the venous or the arterial vasculature and associated with antiphospholipid … of the molecular …

… [20,21] As the pathogenesis of APS has been reviewed in … that may advance our understanding
of APS pathogenesis. … inflammatory molecules (intercellular cell adhesion molecule […

… The antiphospholipid syndrome (APS) is characterized by thrombosis and pregnancy
morbidity in the presence of antiphospholipid antibodies (aPL). Complement is a system of …

… to the pathogenesis of antiphospholipid syndrome. Anticoagulation remains the cornerstone
in the management of antiphospholipid syndrome; … in antiphospholipid syndrome. …

Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial,
venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or …

… Antiphospholipid syndrome (APS) is an acquired thromboinflammatory disorder characterized
by the presence of antiphospholipid … complement in the pathophysiology of thrombosis in …

… The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
presence of antiphospholipid antibodies (aPL) leading to arterial and venous thrombosis and …

… The site of binding on the prothrombin molecule is still under … recognize different sites of the
prothrombin molecule.[29] So … the phospholipid-binding site of the prothrombin molecule. A …